Existing methods for preoperative diagnosis of lymph node metastasis are inadequate.

Getty Images


January 24, 2024 — Nonfunctional pancreatic neuroendocrine tumors, while rare, are primarily treated through surgery. The presence or absence of lymph node metastasis considerably influences the selection of surgical and other treatment approaches. Particularly controversial is the necessity of surgery for tumors smaller than 2 cm as current clinical guidelines provide no clear consensus. Existing methods for preoperative diagnosis of lymph node metastasis are inadequate. 

To address the aforementioned challenge, the Tsukuba team has created a predictive model by integrating radiomics features extracted from CT and MRI images using artificial intelligence deep-learning techniques. This model has demonstrated an 89% success rate in predicting lymph node metastasis, a rate that rises to 91% when the model is validated with data from an external hospital. Furthermore, the performance of the model remains consistent, irrespective of the tumor size being larger or smaller than 2 cm. 

In conclusion, the model can help predict lymph node metastasis. Moreover, the model equips surgeons with a crucial tool for selecting the most appropriate surgical procedures and treatment strategies, potentially transforming patient outcomes in the challenging medical field. 

 

For more information: https://www.tsukuba.ac.jp/en/ 


Related Content

News | Information Technology

April 25, 2024 — NewVue Inc., a leader in innovative cloud-native radiology workflow solutions, announced a strategic ...

Time April 25, 2024
arrow
News | Enterprise Imaging

April 25, 2024 — International medical imaging IT and cybersecurity company Sectra has signed two contracts to provide ...

Time April 25, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | Artificial Intelligence

April 19, 2024 — Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology ...

Time April 22, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
Subscribe Now